Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations

NCT04378881 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID
Drug Effect
Drug Interaction
Adverse Drug Event

Sponsor

Tabula Rasa HealthCare

Collaborators

[object Object]